370 related articles for article (PubMed ID: 20695750)
1. Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis.
Müller FM; Seidler M
Expert Rev Anti Infect Ther; 2010 Aug; 8(8):957-64. PubMed ID: 20695750
[TBL] [Abstract][Full Text] [Related]
2. [Long-term fungal culture of sputum from patients with cystic fibrosis].
Haase G; Skopnik H; Groten T; Kusenbach G; Posselt HG
Mycoses; 1991; 34 Suppl 1():49-52. PubMed ID: 1818263
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel PCR assay for the identification of the black yeast, Exophiala (Wangiella) dermatitidis from adult patients with cystic fibrosis (CF).
Nagano Y; Elborn JS; Millar BC; Goldsmith CE; Rendall J; Moore JE
J Cyst Fibros; 2008 Nov; 7(6):576-80. PubMed ID: 18571996
[TBL] [Abstract][Full Text] [Related]
4. Fungal infection of cystic fibrosis patients - single center experience.
Garczewska B; Jarzynka S; Kuś J; Skorupa W; Augustynowicz-Kopeć E
Pneumonol Alergol Pol; 2016; 84(3):151-9. PubMed ID: 27238177
[TBL] [Abstract][Full Text] [Related]
5. [The fungal risk in cystic fibrosis: a pilot study].
Van Grunderbeeck N; Conseil V; Leroy S; Wallaert B; Delhaes L
Ann Biol Clin (Paris); 2010; 68(2):157-62. PubMed ID: 20348048
[TBL] [Abstract][Full Text] [Related]
6. Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
Griffard EA; Guajardo JR; Cooperstock MS; Scoville CL
Pediatr Pulmonol; 2010 May; 45(5):508-10. PubMed ID: 20425860
[TBL] [Abstract][Full Text] [Related]
7. Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients.
Nasri E; Fakhim H; Vaezi A; Khalilzadeh S; Ahangarkani F; Laal Kargar M; Abtahian Z; Badali H
Mycoses; 2019 May; 62(5):434-440. PubMed ID: 30681747
[TBL] [Abstract][Full Text] [Related]
8. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
[TBL] [Abstract][Full Text] [Related]
9. [Fungal infections in cystic fibrosis].
Le Bourgeois M; Sermet I; Bailly-Botuha C; Delacourt C; de Blic J
Arch Pediatr; 2011 May; 18 Suppl 1():S15-21. PubMed ID: 21596282
[TBL] [Abstract][Full Text] [Related]
10. Modified culture method detects a high diversity of fungal species in cystic fibrosis patients.
Masoud-Landgraf L; Badura A; Eber E; Feierl G; Marth E; Buzina W
Med Mycol; 2014 Feb; 52(2):179-86. PubMed ID: 23651180
[TBL] [Abstract][Full Text] [Related]
11. Detection of hyphomycetes in the upper respiratory tract of patients with cystic fibrosis.
Horré R; Marklein G; Siekmeier R; Reiffert SM
Mycoses; 2011 Nov; 54(6):514-22. PubMed ID: 20492536
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review.
Pihet M; Carrere J; Cimon B; Chabasse D; Delhaes L; Symoens F; Bouchara JP
Med Mycol; 2009 Jun; 47(4):387-97. PubMed ID: 19107638
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibility patterns for Aspergillus, Scedosporium, and Exophiala isolates recovered from cystic fibrosis patients against amphotericin B, and three triazoles and their impact after long-term therapies.
Brito Devoto T; Hermida-Alva K; Posse G; Finquelievich JL; García-Effrón G; Cuestas ML
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37591630
[TBL] [Abstract][Full Text] [Related]
15. Use of Selective Fungal Culture Media Increases Rates of Detection of Fungi in the Respiratory Tract of Cystic Fibrosis Patients.
Hong G; Miller HB; Allgood S; Lee R; Lechtzin N; Zhang SX
J Clin Microbiol; 2017 Apr; 55(4):1122-1130. PubMed ID: 28100601
[TBL] [Abstract][Full Text] [Related]
16. Exophiala (Wangiella) dermatitidis and cystic fibrosis - Prevalence and risk factors.
Lebecque P; Leonard A; Huang D; Reychler G; Boeras A; Leal T; Symoens F
Med Mycol; 2010 Nov; 48 Suppl 1():S4-9. PubMed ID: 21067329
[TBL] [Abstract][Full Text] [Related]
17. The myriad challenges of respiratory fungal infection in cystic fibrosis.
Tracy MC; Moss RB
Pediatr Pulmonol; 2018 Nov; 53(S3):S75-S85. PubMed ID: 29992775
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
Amorim A; Guedes-Vaz L; Araujo R
Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
[TBL] [Abstract][Full Text] [Related]
19. Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis.
Nagano Y; Elborn JS; Millar BC; Walker JM; Goldsmith CE; Rendall J; Moore JE
Med Mycol; 2010 Feb; 48(1):166-76.e1. PubMed ID: 19672783
[TBL] [Abstract][Full Text] [Related]
20. What is the clinical significance of filamentous fungi positive sputum cultures in patients with cystic fibrosis?
Liu JC; Modha DE; Gaillard EA
J Cyst Fibros; 2013 May; 12(3):187-93. PubMed ID: 23491855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
